|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.10 CHF | +0.77% |
|
-0.67% | -0.34% |
| 07:32pm | Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial | RE |
| Jun. 05 | Zealand touts promising tolerability data for obesity drug in mid-stage study | RE |
MarketScreener Editorial Features
Filters
- Stock Market
- Equities
- ROP Stock
- News Roche Holding AG
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions

















